Maya Zigler

Dr. Maya Zigler has played a major role in the establishment of TargImmune and its activities. Dr Zigler completed her Ph.D at M.D. Anderson Cancer Center, Houston, Texas on melanoma metastases and progression. She has significant expertise and specialized knowledge in cancer biology. Dr. Zigler joined Professor Alex Levitzki’s laboratory as a postdoc in 2011 where she conducted extensive research, focused on expanding and improving the Ta:RNA technology to target additional cancer targets.

She secured the ERC POC grant in 2013 for the Levitzki laboratory to pursue the Ta:RNA technology and is named as co-inventor on a filed patent on the Ta:RNA technology.

Dr. Zigler has co-authored 22 publications in peer-reviewed journals and won several awards, including the Bob Smith Research Fellowship, MD Anderson Cancer Center 2005-2008, Joanna M. Nicolay Melanoma Foundation 2010 and the Lady Davis Postdoctoral Fellowship 2013-2015.